An update on therapeutic uses of radiotracers in neoplastic disease.
The key to delivering radiation to a lesion by means of internally administered radiopharmaceuticals is specificity of localization (a high lesion-background ratio). Factors that may limit this localization are pointed out. Potential alteration of the residence time within the lesion and use of radiation-sensitizing agents may bring new applications for radionuclides in therapy. The most common therapeutic applications of radiopharmaceuticals are outlined.
D001610:Beta Particles / Q000627:therapeutic use; D005260:Female; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000627:therapeutic use*
D011868:Radioisotopes